Single LipiFlow Treatment to Reduce Eye Drop Use
Part of Eyes & vision clinical trials.
This study tests whether a single LipiFlow treatment (a warm compress machine for the eyelids) can help people with dry eye disease use fewer prescription eye drops. It may be a good option if you have been using drops like Xiidra or Restasis for a long time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have not had any previous treatments for meibomian glands (like LipiFlow, TearCare, or I-Lux).
- You use lifitegrast or cyclosporine eye drops every day for at least 1 year but no more than 5 years.
- A special test (meibography) shows that you still have at least half of your meibomian glands working.
- You do not have ocular rosacea, eye infections, or other eye conditions that could affect the results.
- You have not had eye surgery, injury, or certain infections in the past 3 months.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special eyelid massage technique using a support plate can help unblock and improve meibomian glands—small glands in your eyelids that produce tear oil. If your glands are blocked or not working well, it may be causing your dry eyes, and this treatment might help.
This study tests whether TearCare, a device that warms and massages the eyelids, can help young adults with dry eyes caused by blocked oil glands. The trial measures whether the treatment improves tear quality and eye comfort.
This study tests whether low-level light therapy can improve dry eye symptoms caused by blocked oil glands (Meibomian Gland Dysfunction). It also looks at how the treatment affects skin pigmentation under the eyes.
This trial tests a non-invasive radiofrequency treatment for people with meibomian gland dysfunction (a type of dry eye) that hasn't improved with standard treatments. It aims to see if this therapy can safely help your eyes feel better.
This trial tests if a new eye drop (perfluorohexyloctane) is safe and effective for treating dry eye caused by meibomian gland dysfunction (a common condition where the oil glands in your eyelids don't work properly). It may help if you have this type of dry eye and are looking for a new option.
This study tests heated devices to see if they improve dry eye caused by blocked meibomian (eyelid oil) glands. It may help if warm compresses and gentle eyelid massage didn’t work for you.
Hear when a new MGD-Meibomian Gland Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.